R/R GRADE 4 GLIOMA

Clinical trials for R/R GRADE 4 GLIOMA explained in plain language.

Never miss a new study

Get alerted when new R/R GRADE 4 GLIOMA trials appear

Sign up with your email to follow new studies for R/R GRADE 4 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental cell therapy takes on deadliest brain tumors

Disease control Not yet recruiting

This early-phase study tests a new cell therapy called TH-CART-027 in 21 adults with recurrent or progressive grade 4 glioma, a fast-growing brain cancer. The treatment uses specially engineered immune cells to attack the tumor. The main goals are to check safety and see if the t…

Matched conditions: R/R GRADE 4 GLIOMA

Phase: EARLY_PHASE1 • Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine • Aim: Disease control

Last updated Apr 28, 2026 13:02 UTC

R/R GRADE 4 GLIOMA

Get alerted when new R/R GRADE 4 GLIOMA trials appear

Experimental cell therapy takes on deadliest brain tumors